Evaluating the Efficacy of a Mobile App (Drinks:Ration) and Personalized Text and Push Messaging to Reduce Alcohol Consumption in a Veteran Population: Protocol for a Randomized Controlled Trial.

SMS text messaging alcohol misuse intervention push notifications smartphone

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
02 Oct 2020
Historique:
received: 13 05 2020
accepted: 11 08 2020
revised: 10 08 2020
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 3 10 2020
Statut: epublish

Résumé

Alcohol misuse is higher in the UK Armed Forces than in the general population. Previous research has shown that interventions delivered via smartphones are efficacious in promoting self-monitoring of alcohol use, have utility in reducing alcohol consumption, and have a broad reach. This single-blinded randomized controlled trial (RCT) aims to assess the efficacy of a 28-day brief alcohol intervention delivered via a smartphone app (Drinks:Ration) in reducing weekly self-reported alcohol consumption between baseline and 3-month follow-up among veterans who drink at a hazardous or harmful level and receive or have received support for mental health symptoms in a clinical setting. In this two-arm, single-blinded RCT, a smartphone app that includes interactive features designed to enhance participants' motivation and personalized messaging is compared with a smartphone app that provides only government guidance on alcohol consumption. The trial will be conducted in a veteran population that has sought help through Combat Stress, a UK veteran's mental health charity. Recruitment, consent, and data collection will be carried out automatically through the Drinks:Ration platform. The primary outcome is the change in self-reported weekly alcohol consumption between baseline (day 0) and 3-month follow-up (day 84) as measured using the Time-Line Follow back for Alcohol Consumption. Secondary outcome measures include (1) change in the baseline to 3-month follow-up (day 84) Alcohol Use Disorder Identification Test score and (2) change in the baseline to 3-month follow-up (day 84) World Health Organization Quality of Life-BREF score to assess the quality of adjusted life years. Process evaluation measures include (1) app use and (2) usability ratings as measured by the mHealth App Usability Questionnaire. The primary and secondary outcomes will also be reassessed at the 6-month follow-up (day 168) to assess the longer-term benefits of the intervention, which will be reported as a secondary outcome. The study will begin recruitment in October 2020 and is expected to require 12 months to complete. The study results will be published in 2022. This study assesses whether a smartphone app is efficacious in reducing self-reported alcohol consumption in a veteran population that has sought help through Combat Stress using personalized messaging and interactive features. This innovative approach, if successful, may provide a means to deliver a low-cost health promotion program that has the potential to reach large groups, in particular those who are geographically dispersed, such as military personnel. ClinicalTrials.gov NCT04494594; https://clinicaltrials.gov/ct2/show/NCT04494594. PRR1-10.2196/19720.

Sections du résumé

BACKGROUND BACKGROUND
Alcohol misuse is higher in the UK Armed Forces than in the general population. Previous research has shown that interventions delivered via smartphones are efficacious in promoting self-monitoring of alcohol use, have utility in reducing alcohol consumption, and have a broad reach.
OBJECTIVE OBJECTIVE
This single-blinded randomized controlled trial (RCT) aims to assess the efficacy of a 28-day brief alcohol intervention delivered via a smartphone app (Drinks:Ration) in reducing weekly self-reported alcohol consumption between baseline and 3-month follow-up among veterans who drink at a hazardous or harmful level and receive or have received support for mental health symptoms in a clinical setting.
METHODS METHODS
In this two-arm, single-blinded RCT, a smartphone app that includes interactive features designed to enhance participants' motivation and personalized messaging is compared with a smartphone app that provides only government guidance on alcohol consumption. The trial will be conducted in a veteran population that has sought help through Combat Stress, a UK veteran's mental health charity. Recruitment, consent, and data collection will be carried out automatically through the Drinks:Ration platform. The primary outcome is the change in self-reported weekly alcohol consumption between baseline (day 0) and 3-month follow-up (day 84) as measured using the Time-Line Follow back for Alcohol Consumption. Secondary outcome measures include (1) change in the baseline to 3-month follow-up (day 84) Alcohol Use Disorder Identification Test score and (2) change in the baseline to 3-month follow-up (day 84) World Health Organization Quality of Life-BREF score to assess the quality of adjusted life years. Process evaluation measures include (1) app use and (2) usability ratings as measured by the mHealth App Usability Questionnaire. The primary and secondary outcomes will also be reassessed at the 6-month follow-up (day 168) to assess the longer-term benefits of the intervention, which will be reported as a secondary outcome.
RESULTS RESULTS
The study will begin recruitment in October 2020 and is expected to require 12 months to complete. The study results will be published in 2022.
CONCLUSIONS CONCLUSIONS
This study assesses whether a smartphone app is efficacious in reducing self-reported alcohol consumption in a veteran population that has sought help through Combat Stress using personalized messaging and interactive features. This innovative approach, if successful, may provide a means to deliver a low-cost health promotion program that has the potential to reach large groups, in particular those who are geographically dispersed, such as military personnel.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT04494594; https://clinicaltrials.gov/ct2/show/NCT04494594.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
PRR1-10.2196/19720.

Identifiants

pubmed: 33006569
pii: v9i10e19720
doi: 10.2196/19720
pmc: PMC7568221
doi:

Banques de données

ClinicalTrials.gov
['NCT04494594']

Types de publication

Journal Article

Langues

eng

Pagination

e19720

Subventions

Organisme : Medical Research Council
ID : MR/N028244/1
Pays : United Kingdom

Informations de copyright

©Daniel Leightley, Roberto J Rona, James Shearer, Charlotte Williamson, Cerisse Gunasinghe, Amos Simms, Nicola T Fear, Laura Goodwin, Dominic Murphy. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 02.10.2020.

Références

Psychiatr Serv. 2014 Jan 1;65(1):98-105
pubmed: 24037454
J Med Internet Res. 2009 Apr 24;11(2):e13
pubmed: 19403466
Arch Intern Med. 2008 Mar 10;168(5):530-6
pubmed: 18332300
Am J Drug Alcohol Abuse. 2017 Sep;43(5):545-555
pubmed: 28410002
J Stud Alcohol. 2004 May;65(3):363-70
pubmed: 15222593
JAMA. 2001 Apr 18;285(15):2006-7
pubmed: 11308440
Addict Behav. 2015 Mar;42:203-6
pubmed: 25482365
JMIR Mhealth Uhealth. 2019 Apr 11;7(4):e11500
pubmed: 30973342
Milbank Q. 2005;83(4):691-729
pubmed: 16279964
Psychol Health. 2009 Jul;24(6):677-87
pubmed: 20205020
Addict Sci Clin Pract. 2012 Aug 28;7:17
pubmed: 23186354
J Ment Health. 2019 Feb;28(1):34-41
pubmed: 30445899
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
IEEE J Biomed Health Inform. 2017 Jul;21(4):939-948
pubmed: 27254874
Lancet. 2010 May 22;375(9728):1783-97
pubmed: 20471076
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
J Ment Health. 2019 Dec;28(6):654-661
pubmed: 28982279
Ann Behav Med. 1996 Fall;18(4):290-304
pubmed: 18425675
Digit Health. 2019 Apr 12;5:2055207619842986
pubmed: 31019722
Addict Behav. 2019 May;92:14-19
pubmed: 30572207
Eur J Psychotraumatol. 2019 Jan 14;10(1):1556552
pubmed: 30693074
Addiction. 2007 Nov;102(11):1749-59
pubmed: 17935583
Eur J Prev Cardiol. 2014 Apr;21(4):492-9
pubmed: 22605787
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
JMIR Mhealth Uhealth. 2019 May 24;7(5):e12267
pubmed: 31127726
BMJ Open. 2016 Sep 16;6(9):e011667
pubmed: 27638494
BMC Public Health. 2016 Jul 08;16:536
pubmed: 27392430
Cochrane Database Syst Rev. 2017 Sep 25;9:CD011479
pubmed: 28944453
Int Rev Psychiatry. 2011 Apr;23(2):166-72
pubmed: 21521086
Behav Res Ther. 1979;17(2):157-60
pubmed: 426744
Br J Psychiatry. 2018 Dec;213(6):690-697
pubmed: 30295216
Occup Med (Lond). 2020 Jun 20;70(4):259-267
pubmed: 31961932
Acta Psychiatr Scand. 2018 Dec;138(6):536-546
pubmed: 30178492
Alcohol Clin Exp Res. 2004 Apr;28(4):608-18
pubmed: 15100612
Addict Behav. 2017 Dec;75:130-137
pubmed: 28734152
Addiction. 2012 Aug;107(8):1431-40
pubmed: 22340523
Drug Alcohol Depend. 2010 Apr 1;108(1-2):37-42
pubmed: 20047802
Ann Fam Med. 2010 Jul-Aug;8(4):348-53
pubmed: 20644190
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
Addict Behav. 2016 Nov;62:25-34
pubmed: 27310031
JMIR Mhealth Uhealth. 2018 Sep 11;6(9):e10074
pubmed: 30206054
Alcohol Res. 2014;36(1):111-22
pubmed: 26259005
J Med Internet Res. 2014 Jun 02;16(6):e142
pubmed: 24892426
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD004148
pubmed: 17443541
J Open Res Softw. 2018 Mar 23;6:13
pubmed: 29795769
J Stud Alcohol Drugs. 2013 May;74(3):500-4
pubmed: 23490581
JMIR Hum Factors. 2018 Jul 10;5(3):e23
pubmed: 29991469
Psychiatr Serv. 2013 Feb 1;64(2):134-41
pubmed: 23475498
Alcohol Alcohol. 2004 Jan-Feb;39(1):29-32
pubmed: 14691071
Psychol Med. 2017 Aug;47(11):1880-1892
pubmed: 28290262
Br J Cancer. 2011 Dec 6;105 Suppl 2:S77-81
pubmed: 22158327
JMIR Mhealth Uhealth. 2017 Apr 25;5(4):e56
pubmed: 28442453
Drug Alcohol Depend. 2017 Sep 1;178:571-578
pubmed: 28750345

Auteurs

Daniel Leightley (D)

King's College London, King's Centre for Military Health Research, London, United Kingdom.

Roberto J Rona (RJ)

King's College London, King's Centre for Military Health Research, London, United Kingdom.

James Shearer (J)

King's College London, King's Health Economics, London, United Kingdom.

Charlotte Williamson (C)

Combat Stress, Leatherhead, United Kingdom.

Cerisse Gunasinghe (C)

King's College London, Department of Psychological Medicine, London, United Kingdom.

Amos Simms (A)

Academic Department of Military Mental Health, King's College London, London, United Kingdom.
British Army, London, United Kingdom.

Nicola T Fear (NT)

King's College London, King's Centre for Military Health Research, London, United Kingdom.
Academic Department of Military Mental Health, King's College London, London, United Kingdom.

Laura Goodwin (L)

University of Liverpool, Department of Psychological Sciences, Liverpool, United Kingdom.

Dominic Murphy (D)

King's College London, King's Centre for Military Health Research, London, United Kingdom.
Combat Stress, Leatherhead, United Kingdom.

Classifications MeSH